262 related articles for article (PubMed ID: 27681573)
21. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
22. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
Drago M; Scaltrito MM; Morace G;
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
25. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.
Lockhart SR; Messer SA; Gherna M; Bishop JA; Merz WG; Pfaller MA; Diekema DJ
J Clin Microbiol; 2009 Apr; 47(4):1216-7. PubMed ID: 19193845
[TBL] [Abstract][Full Text] [Related]
26. Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile.
Amanloo S; Shams-Ghahfarokhi M; Ghahri M; Razzaghi-Abyaneh M
Med Mycol; 2018 Feb; 56(2):207-215. PubMed ID: 28482076
[TBL] [Abstract][Full Text] [Related]
27. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Szweda P; Gucwa K; Naumiuk L; Romanowska E; Dzierzanowska-Fangrat K; Brillowska-Dabrowska A; Wojciechowska-Koszko I; Milewski S
Acta Microbiol Immunol Hung; 2014 Jun; 61(2):161-72. PubMed ID: 24939684
[TBL] [Abstract][Full Text] [Related]
29. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
30. Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR.
Arastehfar A; Fang W; Pan W; Liao W; Yan L; Boekhout T
BMC Infect Dis; 2018 Sep; 18(1):480. PubMed ID: 30253748
[TBL] [Abstract][Full Text] [Related]
31. Candida nivariensis in comparison to different phenotypes of Candida glabrata.
Swoboda-Kopeć E; Sikora M; Golas M; Piskorska K; Gozdowski D; Netsvyetayeva I
Mycoses; 2014 Dec; 57(12):747-53. PubMed ID: 25267284
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
Li J; Shan Y; Fan S; Liu X
Mycopathologia; 2014 Oct; 178(3-4):279-83. PubMed ID: 25118875
[TBL] [Abstract][Full Text] [Related]
33. The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods.
Ben-Ami R; Hilerowicz Y; Novikov A; Giladi M
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):209-13. PubMed ID: 24657169
[TBL] [Abstract][Full Text] [Related]
34. [First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula].
López-Soria LM; Bereciartua E; Santamaría M; Soria LM; Hernández-Almaraz JL; Mularoni A; Nieto J; Montejo M
Rev Iberoam Micol; 2013 Jan; 30(1):69-71. PubMed ID: 22982698
[TBL] [Abstract][Full Text] [Related]
35. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
[TBL] [Abstract][Full Text] [Related]
36. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Chen TC; Chen YH; Chen YC; Lu PL
Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
[TBL] [Abstract][Full Text] [Related]
37. Mating genotypes and susceptibility profiles of clinical isolates of Candida glabrata from Turkey.
Kaplan E; Aktaş D; Önder Ş; Metin B; Döğen A; Oz Y; Ilkit M
Mycoses; 2019 Sep; 62(9):796-802. PubMed ID: 31134666
[TBL] [Abstract][Full Text] [Related]
38. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
39. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
40. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
